Randomised controlled trial of combined diphtheria, tetanus, whole-cell pertussis vaccine administered in the same syringe and separately with Haemophilus influenzae type b vaccine at two, three and four months of age

Vaccine

Volumn 16, Issue 1, 1998, Pages 109-113

  Jones, Ian G ^a   Tyrrell, Helen ^b   Hill, Anthony ^c   Horobin, Jean M ^a   Taylor, Brent ^d  

^a Centre Health and Social Research   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c South Humber Health Authority   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Diphtheria tetanus pertussis vaccine; Haemophilus influenzae b vaccine; Randomized controlled trial

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INFANT; INJECTION; INJECTION SITE; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYRINGE; TETANUS; UNITED KINGDOM;

EID: 0031986551     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00161-8     Document Type: Article

References (13)

1. Department of Health, Welsh Office, Scottish Office Home and Health Department, DHSS (Northern Ireland), Immunisation against infectious disease, HMSO, London, 1992.
2. Salisbury, D.M. and Begg, N.T., eds., Department of Health, Welsh Office, Scottish Office Home and Health Department, DHSS (Northern Ireland), 1996 Immunisation against infectious disease, Edward Jenner bicentenary edition, HMSO, London, 1996.
3. Begg N.T., Miller E., Fairley C.K., Chapel H.M., Griffiths H., Waight P.A., Ashworth L.A.E. Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type b conjugate vaccines given for primary immunisation by separate or mixed injection. Vaccine. 13:1995;1547-1550.
4. Mulholland E.K., Ahonkhai V.I., Greenwood A.M., Jonas L.C., Lukacs L.J., Mink C.M., Staub J.M., Todd J., Vella P.P., Greenwood B.M. Safety and immunogenicity of Haemophilus influenzae type b-Neisseria meningitidis Group B outer membrane protein complex conjugate vaccine mixed in the syringe with diphtheria-tetanus-pertussis vaccine in young Gambian infants. Paediatr. Infect. Dis. J. 12:1993;632-637.
5. Black, S.B., Shinefield, H.R., Ray, P., Lewis, E.M., Fireman, B., Hiatt, R. and The Kaiser Permanente Pediatric Vaccine Study Group, Madore, D.V., Johnson, C.L. and Hackell, J.G., Safety of combined oligosaccharide conjugate Haemophilus influenzae type b (HbOC) and whole cell diphtheria-tetanus toxoids-pertussis vaccine in infancy. Pediatr. Infect. Dis. J. 1993, 12, 981-985.
6. Paradiso P.R., Hogerman D.A., Madore D.V., Keyserling H., King J., Reisinger K.S., Blatter M.M., Rothstein E., Bernstein H.H. Pennridge Pediatric Associates and Hackell J. Safety and immunogenicity of a combined diphtheria, tetanus, pertussis and Haemophilus influenzae type b vaccine in young infants. Pediatrics. 92:1993;827-832.
7. Barra A., Dagan R., Preud'homme J.L., Bajart A., Danve B., Fritzell B. Characterization of the serum antibody response induced by Haemophilus influenzae type b tetanus protein-conjugate vaccine in infants receiving a DTP-combined vaccine from 2 months of age. Vaccine. 11:1993;1003-1006.
8. Watemberg N., Dagan R., Arbelli Y., Belmaker I., Morag A., Hessel L., Fritzell B., Bajard A., Peyron L. Safety and immunogenicity of Haemophilus type-b tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr. Infect. Dis. J. 10:1991;758-761.
9. Kaplan S.L., Lauer B.A., Ward M.A., Wiedermann B.L., Boyer K.M., Dukes C.M., Schaffer D.M., Paisley J., Mendelson R., Pedreira F., Fritzell B. Immunogenicity and safety of Haemophilus influenzae type-b tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants. J. Pediatr. 124:1994;323-327.
10. Ferreccio C., Clemens J., Avendano A., Horwitz I., Flores C., Avila L., Cayazzo M., Fritzell B., Cadoz M., Levine M. The clinical and immunological responses of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoid-pertussis vaccine at two, four and six months of age. Pediatr. Infect. Dis. J. 10:1991;764-771.
11. Clemens J., Ferreccio C., Levine M.M., Horwitz I., Rao M.R., Edwards K.M., Fritzell B. Impact of Haemophilus influenzae type-b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. JAMA. 267:1992;673-678.
12. Scheifele D., Barreto L., Meekison W., Guasparini R., Friesen B. Can Haemophilus influenzae type-b tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? Can. Med. Assoc. J. 149:1993;1105-1112.
13. Gold R., Scheifele D., Barreto L., Wiltsey S., Bjornson G., Meekison W., Guasparini R., Medd L. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr. Infect. Dis. J. 13:1994;348-355.